Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Raymond H. Kang, MA
Advertisement
Articles by Raymond H. Kang, MA
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
3
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
4
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
5